CKD

Clinical trials for CKD explained in plain language.

Never miss a new study

Get alerted when new CKD trials appear

Sign up with your email to follow new studies for CKD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 10 Not yet recruiting 3 Not yet finished but already full! 3 Completed 6 Terminated 1

New drug aims to shield kidneys during heart surgery

Disease control Terminated

This study tests a single dose of ravulizumab given before heart surgery to see if it can prevent kidney damage and serious kidney problems in people with chronic kidney disease. About 736 adults will take part. The goal is to reduce the risk of major kidney events within 90 days…

Matched conditions: CKD

Phase: PHASE3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control

Last updated Jul 24, 2026 00:00 UTC

CKD

Get alerted when new CKD trials appear

New drug aims to shield kidneys during heart surgery